This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Innotherapy Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations by Suk Song Oh in Hemostatic Technology.
Introduction
Suk Song Oh is an accomplished inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of medical technology, particularly in the development of innovative devices that enhance patient care.
Latest Patents
One of his notable patents is the "Hemostatic injection needle coated with crosslinked chitosan having catechol group and oxidized catechol group." This invention relates to a hemostatic injection needle that is designed to suppress bleeding during and after injection. The unique coating of chitosan, which incorporates catechol groups, allows for effective use in patients with low hemostatic ability, including those with coagulopathy, diabetes, and those undergoing anticancer treatment.
Career Highlights
Suk Song Oh has been instrumental in advancing medical technologies through his innovative designs. His work has not only improved the safety and efficacy of injections but has also provided solutions for patients who are prone to bleeding complications.
Collaborations
He has collaborated with talented individuals such as Haeshin Lee and Mikyung Shin, who have contributed to his research and development efforts.
Conclusion
Suk Song Oh's contributions to the field of hemostatic technology exemplify the impact of innovation in improving medical practices. His work continues to pave the way for advancements that enhance patient safety and care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile